Type 2 & other diabetes

Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward

Lancet Diabetes EndocrinolPublished Literature review

Authors' conclusion

The range of disparities in diabetes prevalence and management in the USA calls for a community-engaged and multidisciplinary approach that must involve community partners, researchers, practitioners, health system administrators, and policy makers.

Study context

Population
Racial and ethnic groups in the USA, including young people (aged <18 years), with or at risk of T2D
Outcome
T2D disparities by race and ethnicity

Main finding

As reported in the abstract

  • T2D disparities in the USA persist in both prevalence of disease and diabetes-related complications
  • Causes of disparities categorised in five domains: health behaviours and social norms, public awareness, structural racism, economic development, and access to high-quality care

Original publication

Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward. Lancet Diabetes Endocrinol. Published 22 June 2023. doi:10.1016/s2213-8587(23)00129-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.